Skip to main content

Animations

MJFF Publications

3741 - 3750 of 8571 Results
Title
Year
  • Year
  • 2024
  • 2007
  • 2016
  • 2017
  • 2023
  • 2021
  • 2024
  • 2008
  • 2019
  • 2019
  • Summary Details
    RESTRICTED
    Title: Concerns with the new biological research criteria for synucleinopathy – Authors' reply
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(24)00233-3
    Best OA location URL:
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: Special focus section: Gene therapy for Parkinson's disease
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2007.09.006
    Best OA location URL:
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Enabling breakthroughs in Parkinson’s disease with wearable technologies and big data analytics
    Journal Name: mHealth
    Publisher: AME Publishing Company
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.21037/mhealth.2016.04.02
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Beliefs About Use of Complementary Health Approaches for Parkinson's Disease
    Journal Name: Holistic Nursing Practice
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/hnp.0000000000000229
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Good Practices Report of an ISPOR Task Force
    Journal Name: Value in Health
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.jval.2022.12.006
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson’s disease progression
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-021-00042-6
    Citation Count: 47
  • Summary Details
    RESTRICTED
    Title: Revised criteria for the diagnosis and staging of Alzheimer’s disease
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41591-024-02988-7
    Citation Count: 53
  • Summary Details
    RESTRICTED
    Title: Morphometric analysis of hypothalamic cells showing c-Fos proteins after movement restriction and EHF-irradiation
    Journal Name: Pathophysiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.pathophys.2007.11.001
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
    Journal Name: Journal of Visualized Experiments
    Publisher: MyJove Corporation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3791/59758
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-018-0073-1
    Citation Count: 29
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.